Medication info

Macid Injection (Triamcinolone Acetonide)

Prescription medicationInjectionsInjection
Ingredient · strength
Triamcinolone Acetonide›40mg / 1 vial
Manufacturer / importer
Hanmi Pharm. Co.,Ltd.
Appearance
An injectable solution containing a white crystalline powder in a colorless transparent vial
Packaging
1 vial/carton
Approval status
Active

MFDS item code 201500481 · Approved 2015.01.30 · Insurance code 643507101

Summary

Main use
Visualization of the vitreous during vitrectomy; treatment of diabetic macular edema
Who receives it
Adults
Adult administration
1. Visualization of the vitreous during vitrectomy Inject 4mL of normal saline or ocular irrigating solution into 1 vial to make the concentration of triamcinolone acetonide 10mg/mL. At the time of use, inject 0.5~4mg of triamcinolone acetonide (0.05~0.4mL of suspension) into the vitreous. The concentration of triamcinolone acetonide may be adjusted according to the patient's condition, but should not exceed 40mg/mL. 2. Diabetic macular edema Inject 1mL of normal saline or ocular irrigating solution into 1 vial to make the concentration of triamcinolone acetonide 40mg/mL. At the time of use, inject 4mg of triamcinolone acetonide (0.1mL of suspension) into the vitreous. The efficacy and safety of administration more than once have not been established. Repeat administration may increase the risk of cataracts. Repeat administration should be performed at intervals of at least 3 months and only when, based on the patient's condition, the therapeutic benefit is considered to outweigh the risk. It should be performed after the disappearance of triamcinolone acetonide particles has been confirmed using slit-lamp microscopy or a similar method. In clinical trials, treatment of both eyes was not performed. Therefore, if both eyes have lesions requiring treatment, carefully evaluate the benefits and risks of treating both eyes simultaneously before administering this product. In addition, avoid simultaneous administration to both eyes at the first treatment; treat the other eye only after the safety of treatment in one eye has been adequately evaluated.

Ingredients

Importer
Hanmi Pharm. Co.,Ltd.

Efficacy & effects

Visualization of the vitreous during vitrectomy; treatment of diabetic macular edema

  • Diabetic macular edema
View approved original text

This medication helps to visualize the vitreous during vitreous surgery and is also used for the treatment of diabetic macular edema.

How it is given

Adult administration

1. Visualization of the vitreous during vitrectomy Inject 4mL of normal saline or ocular irrigating solution into 1 vial to make the concentration of triamcinolone acetonide 10mg/mL. At the time of use, inject 0.5~4mg of triamcinolone acetonide (0.05~0.4mL of suspension) into the vitreous. The concentration of triamcinolone acetonide may be adjusted according to the patient's condition, but should not exceed 40mg/mL. 2. Diabetic macular edema Inject 1mL of normal saline or ocular irrigating solution into 1 vial to make the concentration of triamcinolone acetonide 40mg/mL. At the time of use, inject 4mg of triamcinolone acetonide (0.1mL of suspension) into the vitreous. The efficacy and safety of administration more than once have not been established. Repeat administration may increase the risk of cataracts. Repeat administration should be performed at intervals of at least 3 months and only when, based on the patient's condition, the therapeutic benefit is considered to outweigh the risk. It should be performed after the disappearance of triamcinolone acetonide particles has been confirmed using slit-lamp microscopy or a similar method. In clinical trials, treatment of both eyes was not performed. Therefore, if both eyes have lesions requiring treatment, carefully evaluate the benefits and risks of treating both eyes simultaneously before administering this product. In addition, avoid simultaneous administration to both eyes at the first treatment; treat the other eye only after the safety of treatment in one eye has been adequately evaluated.

Precautions

This medication is an injectable solution administered directly into the eye and is primarily used to treat ophthalmic conditions. The risk of cataracts and increased intraocular pressure may rise with re-administration, and the effectiveness may be lower than before, so it should be used with caution. It should not be administered to patients with a history of allergic reactions to its components, those with eye infections or suspected infections, patients with uncontrolled glaucoma, or those without a lens. Caution should be exercised when administering to patients with glaucoma, high intraocular pressure, cataracts, and those who have recently undergone eye surgery or laser treatment, due to the risk of infection. After administration, there is a risk of serious side effects such as increased intraocular pressure, worsening of cataracts, and endophthalmitis, so the patient’s condition should be closely monitored and any abnormal symptoms reported to a physician immediately. Blood glucose management is important in patients with diabetic macular edema, and careful observation is required as this medication can influence blood glucose control. Pregnant women or women of childbearing age, children, and the elderly should be especially cautious when administered this medication, as its safety in pregnant women has not been established. This drug is administered only intra-vitreally, must be used in a sterile condition, and the remaining solution from a vial should not be used for multiple patients but discarded instead. After administration, the eye should be regularly examined, and monitoring should continue until the drug is completely eliminated. Additionally, when used in conjunction with oral diabetic medications or insulin, the effectiveness may be reduced, so the patient's condition should be carefully observed.

Side effects

Increased intraocular pressure, hypotension during surgery, cataract, floaters, visual impairment, diffusion of drug within the vitreous body, increased blood glucose, increased potassium in the blood, increased blood triglycerides, increased serum lactate dehydrogenase, positive glucose in urine, neglect, foreign body sensation in the eye, increased basophils, increased eosinophils, decreased platelet count, worsening of diabetes, endophthalmitis, visual disability, retinal detachment, glaucoma, retinopathy, exacerbation of cataracts, ocular abnormalities, vitreous hemorrhage, bowel obstruction, gallbladder disease, hyperkalemia, benign breast tumor in females, worsening of angina, conjunctivitis, uveitis, macular edema, thinning of the cornea, conjunctival disease, choroidal-retinal disorder, unspecified vitreous disease, blepharitis, ocular pain, allergic conjunctivitis, secondary glaucoma, conjunctival hemorrhage, congestion, dry eye syndrome, enteritis, hypertrophic muscle spasms, spinal canal stenosis, diabetic foot ulcer, increased urinary leukocytes, neovascularization, urticaria, malignant breast tumor in females

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent exposure to air, and it is recommended to store it at room temperature between 1°C and 30°C. By storing it this way, the effectiveness of the medication can be well maintained.

Appearance and packaging

Appearance

An injectable solution containing a white crystalline powder in a colorless transparent vial

Package unit

1 vial/carton

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.